Monday, October 26, 2026 · Daily editionET --:--:--

Status not kept up to date

EEG Brain-Machine Interface Control of an Upper-Limb Robotic Exoskeleton for Robot-Assisted Rehabilitation After Stroke

NCT05374486 · University of Houston · Updated 16 May 2022

What is being tested
NeuroExo co-robot neurorehabilitation system
For
Stroke; Hemiparesis
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 20 years to 65 years. About 30 people. The full rules are on the registry page.
Where
United States (3 sites)
When
Starts or started 25 April 2022, ends Aug 2022. Registered 16 May 2022.
Results
None posted yet.

In the researchers' words

The goal of this study is to develop a clinically feasible, low-cost, nonsurgical neurorobotic system for restoring function to motor-impaired stroke survivors that can be used at the clinic or at home. Moreover, another goal is to understand how physical rehabilitation assisted by robotic device combined with electroencephalograph (EEG) can benefit adults who have had stroke to improve functions of their weaker arm. The proposed smart co-robot training system (NeuroExo) is based on a physical upper-limb robotic exoskeleton commanded by a non-invasive brain machine interface (BMI) based on scalp EEG to actively include the participant in the control loop . The study will demonstrate that the Neuroexo smart co-robot arm training system is feasible and effective in improving arm motor functions in the stroke population for their use at home.The NeuroExo study holds the promise to be cost-effective patient-centered neurorehabilitation system for improving arm functions after stroke.
ClinicalTrials.gov, NCT05374486

Sites

  • The Institute for Rehabilitation and Research (TIRR) at Memorial HermannHouston, Texas, United States
  • TIRR Memorial Hermann HospitalHouston, Texas, United States
  • University of HoustonHouston, Texas, United States